{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:30:42Z","timestamp":1760488242959,"version":"build-2065373602"},"reference-count":71,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2025.2048","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:39:01Z","timestamp":1756283941000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["<i>Puerariae radix<\/i> flavones induce apoptosis in bladder cancer T24 cells via the FAS\/TNFR1 pathway: A potential therapeutic candidate"],"prefix":"10.3892","volume":"23","author":[{"given":"Jing","family":"Dong","sequence":"first","affiliation":[{"name":"College of Public Health, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yupeng","family":"Guo","sequence":"additional","affiliation":[{"name":"College of Public Health, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Ji","sequence":"additional","affiliation":[{"name":"College of Public Health, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjun","family":"Guan","sequence":"additional","affiliation":[{"name":"College of Public Health, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbin","family":"Ma","sequence":"additional","affiliation":[{"name":"College of Science, Harbin University of Science and Technology, Harbin, Heilongjiang 150080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengzhong","family":"Rong","sequence":"additional","affiliation":[{"name":"College of Public Health, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"key20251014125350_b1-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20251014125350_b2-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"key20251014125350_b3-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/jamaoncol.2023.6804","article-title":"Response to 2 induction courses of bacillus Calmette-Gu\u00e8rin therapy among patients with high-risk non-muscle-invasive bladder cancer: 5-Year follow-up of a phase 2 clinical trial","volume":"10","author":"Katims","year":"2024","journal-title":"JAMA Oncol"},{"key":"key20251014125350_b4-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","article-title":"Recurrence mechanisms of non-muscle-invasive bladder cancer-a clinical perspective","volume":"19","author":"Teoh","year":"2022","journal-title":"Nat Rev Urol"},{"key":"key20251014125350_b5-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: New insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"key20251014125350_b6-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"key20251014125350_b7-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/551S34a","article-title":"Unlocking bladder cancer","volume":"551","author":"Berdik","year":"2017","journal-title":"Nature"},{"key":"key20251014125350_b8-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ucl.2013.01.004","article-title":"The costs of non-muscle invasive bladder cancer","volume":"40","author":"James","year":"2013","journal-title":"Urol Clin North Am"},{"key":"key20251014125350_b9-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.canep.2013.02.002","article-title":"Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis","volume":"37","author":"Abdollah","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"key20251014125350_b10-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"issue":"12521","key":"key20251014125350_b11-BR-23-5-02048","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29987-2","article-title":"Racial differences in urinary bladder cancer in the United States","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"key20251014125350_b12-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.canep.2016.04.012","article-title":"Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system","volume":"42","author":"Schinkel","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"key20251014125350_b13-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3233\/BLC-150041","article-title":"Do African American patients treated with radical cystectomy for bladder cancer have worse overall survival? Accounting for pathologic staging and patient demographics beyond race makes a difference","volume":"2","author":"Kaye","year":"2016","journal-title":"Bladder Cancer"},{"key":"key20251014125350_b14-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.juro.2015.01.076","article-title":"The impact of regionalization of cystectomy on racial disparities in bladder cancer care","volume":"194","author":"Casey","year":"2015","journal-title":"J Urol"},{"key":"key20251014125350_b15-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","article-title":"Gender and bladder cancer: A collaborative review of etiology, biology, and outcomes","volume":"69","author":"Dobruch","year":"2016","journal-title":"Eur Urol"},{"key":"key20251014125350_b16-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clgc.2019.10.020","article-title":"Sex Differences in urothelial bladder cancer survival","volume":"18","author":"Radkiewicz","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"key20251014125350_b17-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"key20251014125350_b18-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1001\/jama.2018.4657","article-title":"Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non-muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial","volume":"319","author":"Messing","year":"2018","journal-title":"JAMA"},{"key":"key20251014125350_b19-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1021\/acs.chemrev.8b00211","article-title":"Transition metal complexes and photodynamic therapy from a tumor-centered approach: Challenges, opportunities, and highlights from the development of TLD1433","volume":"119","author":"Monro","year":"2019","journal-title":"Chem Rev"},{"key":"key20251014125350_b20-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"key20251014125350_b21-BR-23-5-02048","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized southwest oncology group study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"key20251014125350_b22-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.urolonc.2017.10.014","article-title":"Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future","volume":"36","author":"Hermans","year":"2018","journal-title":"Urol Oncol"},{"key":"key20251014125350_b23-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1142\/S0192415X19500022","article-title":"Puerarin reduces blood pressure in spontaneously hypertensive rats by targeting eNOS","volume":"47","author":"Shi","year":"2019","journal-title":"Am J Chin Med"},{"key":"key20251014125350_b24-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.biopha.2017.06.045","article-title":"Effect of extract of Pueraria tuberosa on expression of hypoxia inducible factor-1\u03b1 and vascular endothelial growth factor in kidney of diabetic rats","volume":"93","author":"Shukla","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"key20251014125350_b25-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1080\/21691401.2018.1489265","article-title":"Antioxidant and anticancer activities of green synthesized silver nanoparticles using aqueous extract of tubers of Pueraria tuberosa","volume":"46 (Suppl 3)","author":"Satpathy","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"key20251014125350_b26-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11418-013-0788-6","article-title":"Miroestrol, a phytoestrogen from Pueraria mirifica, improves the antioxidation state in the livers and uteri of \u03b2-naphthoflavone-treated mice","volume":"68","author":"Jearapong","year":"2014","journal-title":"J Nat Med"},{"key":"key20251014125350_b27-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/CMAR.S233567","article-title":"Molecular mechanisms of anticancer activities of Puerarin","volume":"12","author":"Ahmad","year":"2020","journal-title":"Cancer Manag Res"},{"key":"key20251014125350_b28-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.bbrc.2008.10.178","article-title":"Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells","volume":"378","author":"Lin","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"key20251014125350_b29-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.3892\/ol.2018.9364","article-title":"Puerarin 6''-O-xyloside possesses significant antitumor activities on colon cancer through inducing apoptosis","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol Lett"},{"issue":"42683","key":"key20251014125350_b30-BR-23-5-02048","doi-asserted-by":"publisher","DOI":"10.1038\/srep42683","article-title":"Mangiferin from Pueraria tuberosa reduces inflammation via inactivation of NLRP3 inflammasome","volume":"7","author":"Bulugonda","year":"2017","journal-title":"Sci Rep"},{"key":"key20251014125350_b31-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4103\/0974-8520.123131","article-title":"Anti-inflammatory effect of Pueraria tuberosa extracts through improvement in activity of red blood cell anti-oxidant enzymes","volume":"34","author":"Pandey","year":"2013","journal-title":"Ayu"},{"key":"key20251014125350_b32-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5582\/bst.2019.01181","article-title":"Anti-oxidant, anti-apoptotic, anti-hypoxic and anti-inflammatory conditions induced by PTY-2 against STZ-induced stress in islets","volume":"13","author":"Srivastava","year":"2019","journal-title":"Biosci Trends"},{"key":"key20251014125350_b33-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/jphp.12931","article-title":"Pueraria tuberosa extract inhibits iNOS and IL-6 through suppression of PKC-\u03b1 and NF-kB pathway in diabetes-induced nephropathy","volume":"70","author":"Shukla","year":"2018","journal-title":"J Pharm Pharmacol"},{"key":"key20251014125350_b34-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s12272-012-0508-x","article-title":"Anti-inflammatory and antioxidant activities of constituents isolated from Pueraria lobata roots","volume":"35","author":"Jin","year":"2012","journal-title":"Arch Pharm Res"},{"key":"key20251014125350_b35-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/BF02973900","article-title":"Constituents of the roots of Pueraria lobata inhibit formation of advanced glycation end products (AGEs)","volume":"29","author":"Kim","year":"2006","journal-title":"Arch Pharm Res"},{"key":"key20251014125350_b36-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1080\/14786419.2018.1484461","article-title":"New hepatoprotective isoflavone glucosides from Pueraria lobata (Willd.) Ohwi","volume":"33","author":"Sun","year":"2019","journal-title":"Nat Prod Res"},{"key":"key20251014125350_b37-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jep.2014.01.008","article-title":"Protective effects of Puerariae radix extract and its single compounds on methylglyoxal-induced apoptosis in human retinal pigment epithelial cells","volume":"152","author":"Sook Kim","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"key20251014125350_b38-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11418-010-0442-5","article-title":"Protection of HT22 neuronal cells against glutamate toxicity mediated by the antioxidant activity of Pueraria candollei var. mirifica extracts","volume":"65","author":"Sucontphunt","year":"2011","journal-title":"J Nat Med"},{"issue":"785","key":"key20251014125350_b39-BR-23-5-02048","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23040785","article-title":"Comparative evaluation of the antioxidant and anti-Alzheimer's disease potential of coumestrol and puerarol isolated from Pueraria lobata using molecular modeling studies","volume":"23","author":"Koirala","year":"2018","journal-title":"Molecules"},{"key":"key20251014125350_b40-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ptr.5595","article-title":"Neurotherapeutic effects of Pueraria mirifica extract in early- and late-stage cognitive impaired rats","volume":"30","author":"Anukulthanakorn","year":"2016","journal-title":"Phytother Res"},{"key":"key20251014125350_b41-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.phymed.2014.06.019","article-title":"Pueraria mirifica extract and Puerarin enhance proliferation and expression of alkaline phosphatase and type I collagen in primary baboon osteoblasts","volume":"21","author":"Tiyasatkulkovit","year":"2014","journal-title":"Phytomedicine"},{"key":"key20251014125350_b42-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/gme.0b013e31815c5fd8","article-title":"Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women","volume":"15","author":"Manonai","year":"2008","journal-title":"Menopause"},{"key":"key20251014125350_b43-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.phymed.2013.03.005","article-title":"Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK\/ERK and PI3K\/Akt activation","volume":"20","author":"Wang","year":"2013","journal-title":"Phytomedicine"},{"key":"key20251014125350_b44-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ijpharm.2012.10.021","article-title":"In vitro and in vivo anticancer activity of a novel Puerarin nanosuspension against colon cancer, with high efficacy and low toxicity","volume":"441","author":"Wang","year":"2013","journal-title":"Int J Pharm"},{"key":"key20251014125350_b45-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3892\/etm.2019.7589","article-title":"Puerarin suppresses cell growth and migration in HPV-positive cervical cancer cells by inhibiting the PI3K\/mTOR signaling pathway","volume":"18","author":"Jia","year":"2019","journal-title":"Exp Ther Med"},{"key":"key20251014125350_b46-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.3892\/mmr.2014.2512","article-title":"Puerarin inhibits growth and induces apoptosis in SMMC-7721 hepatocellular carcinoma cells","volume":"10","author":"Zhang","year":"2014","journal-title":"Mol Med Rep"},{"key":"key20251014125350_b47-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.21873\/anticanres.11837","article-title":"Puerarin induces hepatocellular carcinoma cell apoptosis modulated by MAPK signaling pathways in a dose-dependent manner","volume":"37","author":"Zhang","year":"2017","journal-title":"Anticancer Res"},{"issue":"104594","key":"key20251014125350_b48-BR-23-5-02048","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2020.104594","article-title":"Two pairs of diastereoisomeric isoflavone glucosides from the roots of Pueraria lobata","volume":"144","author":"Hu","year":"2020","journal-title":"Fitoterapia"},{"issue":"37","key":"key20251014125350_b49-BR-23-5-02048","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01517-9","article-title":"Targeting HNRNPU to overcome cisplatin resistance in bladder cancer","volume":"21","author":"Shi","year":"2022","journal-title":"Mol Cancer"},{"key":"key20251014125350_b50-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"921","DOI":"10.31557\/APJCP.2024.25.3.921","article-title":"Cytotoxicity and apoptosis studies of brucein D against T24 bladder cancer cells","volume":"25","author":"Nandana","year":"2024","journal-title":"Asian Pac J Cancer Prev"},{"issue":"125","key":"key20251014125350_b51-BR-23-5-02048","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010125","article-title":"SIRT1 promotes cisplatin resistance in bladder cancer via beclin1 deacetylation-mediated autophagy","volume":"16","author":"Sun","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"450","key":"key20251014125350_b52-BR-23-5-02048","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01242-8","article-title":"Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells","volume":"8","author":"Mun","year":"2022","journal-title":"Cell Death Discov"},{"key":"key20251014125350_b53-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20251014125350_b54-BR-23-5-02048","first-page":"941","article-title":"Effect of Puerariae radix flavones on mRNA expression of N-myc downstream regulatory gene 1 in bladder cancer cell line T24","volume":"41","author":"Dong","year":"2024","journal-title":"J Environ Health"},{"key":"key20251014125350_b55-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: The expanding network of non-apoptotic cell death pathways","volume":"15","author":"Vanden Berghe","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20251014125350_b56-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/cdd.2011.155","article-title":"Regulation of CD95\/Fas signaling at the DISC","volume":"19","author":"Lavrik","year":"2012","journal-title":"Cell Death Differ"},{"key":"key20251014125350_b57-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/sj.cdd.4401186","article-title":"The CD95(APO-1\/Fas) DISC and beyond","volume":"10","author":"Peter","year":"2003","journal-title":"Cell Death Differ"},{"key":"key20251014125350_b58-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1038\/sj.emboj.7601295","article-title":"Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein","volume":"25","author":"Rehm","year":"2006","journal-title":"EMBO J"},{"key":"key20251014125350_b59-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1126\/science.7510905","article-title":"Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule","volume":"263","author":"Cheng","year":"1994","journal-title":"Science"},{"key":"key20251014125350_b60-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.bbamcr.2011.01.026","article-title":"Caspase-8 and bid: Caught in the act between death receptors and mitochondria","volume":"1813","author":"Kantari","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key20251014125350_b61-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/1439-7633(20010105)2:1<20::AID-CBIC20>3.0.CO;2-X","article-title":"Molecular mechanisms of death-receptor-mediated apoptosis","volume":"2","author":"Sartorius","year":"2001","journal-title":"Chembiochem"},{"key":"key20251014125350_b62-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/cdd.2011.121","article-title":"Fas death receptor signalling: Roles of Bid and XIAP","volume":"19","author":"Kaufmann","year":"2012","journal-title":"Cell Death Differ"},{"key":"key20251014125350_b63-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2007.09.016","article-title":"Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation","volume":"41","author":"Li","year":"2008","journal-title":"Cytokine"},{"key":"key20251014125350_b64-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1742-4658.2011.08015.x","article-title":"TNFR1-induced activation of the classical NF-\u03baB pathway","volume":"278","author":"Wajant","year":"2011","journal-title":"FEBS J"},{"key":"key20251014125350_b65-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"key20251014125350_b66-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nature05656","article-title":"Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin","volume":"446","author":"Luo","year":"2007","journal-title":"Nature"},{"key":"key20251014125350_b67-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni0302-221","article-title":"NF-kappaB at the crossroads of life and death","volume":"3","author":"Karin","year":"2002","journal-title":"Nat Immunol"},{"key":"key20251014125350_b68-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ni.2060","article-title":"Inflammation meets cancer, with NF-\u03baB as the matchmaker","volume":"12","author":"Ben-Neriah","year":"2011","journal-title":"Nat Immunol"},{"key":"key20251014125350_b69-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrd2781","article-title":"Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls","volume":"8","author":"Baud","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"key20251014125350_b70-BR-23-5-02048","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s13402-015-0236-6","article-title":"NF-\u03baB signaling in cancer stem cells: A promising therapeutic target?","volume":"38","author":"Vazquez-Santillan","year":"2015","journal-title":"Cell Oncol (Dordr)"},{"key":"key20251014125350_b71-BR-23-5-02048","first-page":"15","article-title":"Effects of Fas, NF-\u03baB and caspases on microvascular endothelial cell apoptosis induced by TNF\u03b1","volume":"8","author":"Cao","year":"2001","journal-title":"Chin J Pathophysiol"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T09:53:58Z","timestamp":1760435638000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2025.2048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":71,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,8,27]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2025.2048","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"type":"print","value":"2049-9434"},{"type":"electronic","value":"2049-9442"}],"subject":[],"published":{"date-parts":[[2025,8,27]]}}}